Live Breaking News & Updates on Travere European

Stay updated with breaking news from Travere european. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58. ....

United States , Tavo Espinoza , Amgen Kyprolis , Todd Davis , Paul Hadden , Matt Hewitt , Matthew Korenberg , Lawrence Solow , Primrose Bio , Merck Vaxneuvance , Karen Reeves , Mattew Korenberg , Matt Korenberg , Jazz Pharmaceuticals , Exchange Commission , Craig Hallum Capital Group , Investment Committee , Ligand Pharmaceuticals Incorporated , Ligand Pharmaceuticals Inc , Call Transcript February , Pharmaceuticals Incorporated , Ligand Fourth Quarter , Chief Financial , Investor Relations , Private Securities Litigation Reform Act , Investor Day ,